- Home
- MRK vs TMO Comparison
MRK vs TMO Comparison
Compare MRK & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | TMO |
|---|---|---|
| Founded | 2000 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.2B | 216.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MRK | TMO |
|---|---|---|
| Price | $102.42 | $585.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 18 |
| Target Price | $109.64 | ★ $615.47 |
| AVG Volume (30 Days) | ★ 14.9M | 1.6M |
| Earning Date | 10-30-2025 | 10-22-2025 |
| Dividend Yield | ★ 3.36% | 0.30% |
| EPS Growth | ★ 58.08 | 8.54 |
| EPS | 7.56 | ★ 17.32 |
| Revenue | ★ $64,235,000,000.00 | $43,736,000,000.00 |
| Revenue This Year | $1.97 | $4.33 |
| Revenue Next Year | $4.96 | $4.94 |
| P/E Ratio | ★ $13.38 | $33.53 |
| Revenue Growth | 1.68 | ★ 3.22 |
| 52 Week Low | $73.31 | $385.46 |
| 52 Week High | $105.84 | $610.97 |
Technical Indicators
Market Signals| Indicator | MRK | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 68.52 | 58.29 |
| Support Level | $100.31 | $577.96 |
| Resistance Level | $105.68 | $597.68 |
| Average True Range (ATR) | 3.06 | 12.81 |
| MACD | 0.52 | -1.75 |
| Stochastic Oscillator | 77.01 | 63.69 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).